Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 31. Juli 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8097  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 161939  
   
Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.
J Thorac Oncol
Movsas B, Hu C, Higgins KA, Ross HJ, Jabbour SK, Kozono D, Owonikoko TK, Xiao C, Shoji T, Faller BA, Mohindra P, Dib EG, Brownstein J, Chun SG, Kuzma CS, Kotecha R, Onitilo A, Mulford D, Paulus R, Bradley JD, Bruner DW.
PMID: 42532339 [PubMed - as supplied by publisher]


Health-Related Quality of Life and Utility Values in Chinese Patients with Non-Small-Cell Lung Cancer: A Multicenter Study.
Value Health
Wang L, Guan X, Wang Y, Hu B, Xie F, Jin X, Li H, NSCLC Survey Group.
PMID: 42532266 [PubMed - as supplied by publisher]


Aptasensors for lung cancer detection.
Talanta
He L, Zhao X, Zhang X, Chen Z, Deng Y, Li S, He N, Liu Y.
PMID: 42531972 [PubMed - as supplied by publisher]


Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with hepatitis B surface antigen positivity: a real-world cohort study.
Lung Cancer
Zhou X, Feng Y, Liang J, Bi X, Zhong Q, Xue L, Wang J, He J, Liu L, Cheng B, Liang W.
PMID: 42531850 [PubMed - as supplied by publisher]


Predictive value of peripheral blood hsa-miR-122-5p and hsa-miR-486-5p for response to neoadjuvant chemoimmunotherapy in lung squamous cell carcinoma.
Transl Oncol
Li G, Cheng X, Su C, Liu Z, Wen T, Ma T.
PMID: 42531729 [PubMed - as supplied by publisher]


Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP).
Clin Exp Metastasis
Chen H, Meng X, Cai L, Lei W, Tang Y, Shi X, Ma L, Zhao J.
PMID: 42530663 [PubMed - indexed for MEDLINE]


Factors influencing participation in lung cancer screening among screening-eligible adults: a scoping review.
Prev Med Rep
Schneider C, Bosso L, Gros L, Durand MA, Selby K, L-Factors Study Group.
PMID: 42529670 [PubMed]


Diagnostic and surgical challenges of pulmonary mucoepidermoid carcinoma: a case report.
J Surg Case Rep
Arroyave-Guerrero Y, Giraldo-Cadavid LF, Garzón JC, Tellez LJ, Ariza Traslaviña JA, Viola L, Páez-Espinel N.
PMID: 42529626 [PubMed]


Ectopic Adrenocorticotropic Hormone Syndrome in a Patient Diagnosed With Lung Adenocarcinoma and Hospitalized Due to Diabetic Ketonuria: A Case Report.
Case Rep Oncol Med
Ay M, Bozkurt E, Özgül E.
PMID: 42529486 [PubMed]


Specific PET Imaging for Precision Management of Lung Cancer: Advances, Clinical Translation and Future Directions.
Chem Biomed Imaging
Chen C, Pan D, Wang X, Xu Y, Yan J, Wang L, Yang M.
PMID: 42529427 [PubMed]


Efficacy of first-line treatment in driver gene-negative non-small cell lung cancer with liver metastases: a Bayesian network meta-analysis.
Front Immunol
Wu W, Guo X, Dong X, Liang H, Zhang L.
PMID: 42529281 [PubMed - indexed for MEDLINE]


Aristolochic acid I accelerates lung adenocarcinoma progression coupled with the upregulation of core oncogenic networks: an integrated network toxicology and experimental study.
Front Pharmacol
Mo L, Yu F, Peng M, He Y, Xie S, Wu S, Zhang Z, Wang C, Zhao W, Ouyang Y, Yi X, Wang L, Peng X, Huang X, Hu Q, Luo J, Chen X, Yang Z.
PMID: 42529069 [PubMed]


Prognostic significance of extracapsular extension in patients with non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a retrospective cohort study.
Front Immunol
Qiu J, Li S, Ge L, Wang S, Hou X, Ling X.
PMID: 42528975 [PubMed - indexed for MEDLINE]


Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety.
Front Immunol
Quan Y, Liang Z, Wei Y, Li H, Zeng Y, Shen J, Su S, Liu X, Huang Z, Wang M, Luo H, Hu Y, Peng J.
PMID: 42528806 [PubMed - indexed for MEDLINE]


Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer.
Front Immunol
Tan JX, Yu HR, Gu Y, Hong H.
PMID: 42528747 [PubMed - indexed for MEDLINE]


Preoperative evaluation of solitary pulmonary nodules and adenocarcinoma invasiveness using ultra-high-resolution computed tomography and multidimensional liquid biopsy: a prospective exploratory study.
Front Oncol
Li Z, Chao S, Li D, Liu C, Wang Y, Zhang G, You S, Zhang X, Wang Y, Ren Y.
PMID: 42528655 [PubMed]


Research progress of small molecule targeted drugs for non-small cell lung cancer.
Front Oncol
Qiu T, Huang X.
PMID: 42528591 [PubMed]


Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience.
Future Oncol
Babel RA, Liu SV, Fan T, Amonkar MM, Velcheti V.
PMID: 42528479 [PubMed - as supplied by publisher]


Same Diagnosis, Different Disease: Why Sex Matters in Lung Cancer.
Respirology
Leong TL, Bonney A.
PMID: 42528283 [PubMed - as supplied by publisher]


The Optimal Lung Cancer Ct Screening Strategy: A Cost-Effectiveness Study Incorporating Nelson Evidence, Evolving Cost of Treatment and Smoking Cessation Interventions.
Int J Cancer
de Nijs K, Ten Haaf K, Moldovanu D, Hubert J, van den Bosch I, van der Aalst C, de Koning HJ.
PMID: 42528272 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 161939    Seite 1 von 8097  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1